Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-13 5:02 pm Purchase | 13G | NKARTA INC NKTX | CITADEL ADVISORS LLC | 3,819,867 5.400% | 3,819,867 (New Position) | View |
| 2024-11-14 4:24 pm Purchase | 13G | Enliven Therapeutics Inc. ELVN | CITADEL ADVISORS LLC | 1,734,094 3.700% | 1,307,237 (+306.25%) | View |
| 2024-11-14 4:23 pm Sale | 13G | Dyne Therapeutics Inc. DYN | CITADEL ADVISORS LLC | 2,960,081 3.000% | -112,506 (-3.66%) | View |
| 2024-11-14 4:21 pm Sale | 13G | DUTCH BROS INC BROS | CITADEL ADVISORS LLC | 2,974,719 2.600% | -1,099,167 (-26.98%) | View |
| 2024-11-14 4:20 pm Purchase | 13G | COMPASS PATHWAYS PLC SPONSORED CMPS | CITADEL ADVISORS LLC | 5,434,676 8.000% | 2,239,159 (+70.07%) | View |
| 2024-11-14 4:20 pm Sale | 13G | Zentalis Pharmaceuticals Inc. ZNTL | CITADEL ADVISORS LLC | 2,737,221 3.900% | -1,001,261 (-26.78%) | View |
| 2024-11-14 4:19 pm Sale | 13G | VISTAGEN THERAPEUTICS INC VTGN | CITADEL ADVISORS LLC | 1,158,219 4.200% | -442,549 (-27.65%) | View |
| 2024-11-14 4:19 pm Sale | 13G | Vigil Neuroscience Inc. VIGL | CITADEL ADVISORS LLC | 1,442,489 3.600% | -719,413 (-33.28%) | View |
| 2024-11-14 4:19 pm Sale | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | CITADEL ADVISORS LLC | 0 0.000% | -2,458,958 (Position Closed) | View |
| 2024-11-14 4:18 pm Sale | 13G | UWM HLDGS CORP UWMC | CITADEL ADVISORS LLC | 8,995,096 7.900% | -17,254 (-0.19%) | View |
| 2024-11-14 4:18 pm Sale | 13G | Aura Biosciences Inc. AURA | CITADEL ADVISORS LLC | 32,626 0.100% | -3,598,868 (-99.10%) | View |
| 2024-11-14 4:18 pm Sale | 13G | REV Group Inc. REVG | CITADEL ADVISORS LLC | 1,336,604 2.600% | -1,360,669 (-50.45%) | View |
| 2024-11-14 4:17 pm Sale | 13G | NETSTREIT CORP NTST | CITADEL ADVISORS LLC | 611,297 0.800% | -3,496,902 (-85.12%) | View |
| 2024-11-14 4:17 pm Purchase | 13G | ATARA BIOTHERAPEUTICS INC ATRA | CITADEL ADVISORS LLC | 260,480 4.600% | 260,480 (New Position) | View |
| 2024-11-14 4:17 pm Sale | 13G | Janux Therapeutics Inc. JANX | CITADEL ADVISORS LLC | 1,021,403 2.000% | -2,104,494 (-67.32%) | View |
| 2024-11-14 4:16 pm Sale | 13G | AN2 Therapeutics Inc. ANTX | CITADEL ADVISORS LLC | 22 0.000% | -1,556,820 (-100.00%) | View |
| 2024-11-14 4:15 pm Sale | 13G | ALLURION TECHNOLOGIES INC ALUR | CITADEL ADVISORS LLC | 100,109 0.200% | -2,463,617 (-96.10%) | View |
| 2024-11-14 4:15 pm Sale | 13G | IMMUNEERING CORP IMRX | CITADEL ADVISORS LLC | 2,672 0.000% | -2,075,420 (-99.87%) | View |
| 2024-11-14 4:14 pm Sale | 13G | Aclaris Therapeutics Inc. ACRS | CITADEL ADVISORS LLC | 368,067 0.500% | -5,038,022 (-93.19%) | View |
| 2024-11-05 4:27 pm Purchase | 13G | CHAIN BRDG BANCORP INC CBNA | CITADEL ADVISORS LLC | 94,882 5.100% | 94,882 (New Position) | View |